Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Medtronic
(NY:
MDT
)
76.15
-0.82 (-1.07%)
Official Closing Price
Updated: 7:00 PM EDT, May 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Medtronic
< Previous
1
2
3
4
5
6
7
8
9
...
64
65
Next >
Stryker Corporation (SYK): Navigating Innovation and Resilience in the Wake of a Digital Crisis
March 16, 2026
As of March 16, 2026, the medical technology landscape is grappling with a stark reminder of the vulnerabilities inherent in the digital shift of healthcare. Stryker Corporation (NYSE: SYK), a global...
Via
Finterra
Topics
Earnings
Economy
Hacking
Medtronic PLC (NYSE:MDT): A Dependable Dividend Stock with Strong Fundamentals
↗
March 16, 2026
Via
Chartmill
Hedge Fund Boone Capital Initiated a Stake in HealthEquity. Is the Stock a Buy?
↗
March 15, 2026
HealthEquity delivers cloud-based healthcare savings solutions to employers and individuals, with a broad client network across the U.S.
Via
The Motley Fool
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
March 12, 2026
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
End of an Era: West Pharmaceutical Shares Slide as Longtime CEO Eric Green Announces Retirement
March 11, 2026
Shares of West Pharmaceutical Services (NYSE: WST) tumbled 5.7% on Tuesday following the announcement that Eric Green, the company’s President, Chief Executive Officer, and Chair of the Board, intends...
Via
MarketMinute
Topics
Economy
Retirement
Safe Haven in a Storm: Healthcare Leads Markets as Geopolitical Tensions Spark Defensive Rotation
March 10, 2026
On a day marked by deepening global uncertainty and a sharp spike in energy costs, the healthcare sector emerged as the primary beneficiary of a massive "risk-off" migration by institutional investors....
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
2 Growth Stocks to Hold for the Next Decade
↗
March 10, 2026
They are down, but they are not out.
Via
The Motley Fool
Topics
World Trade
Deep Dive Into Medtronic Stock: Analyst Perspectives (10 Ratings)
↗
March 10, 2026
Via
Benzinga
Medtronic's $550 Million Scientia Vascular Deal Aims To Boost Neurovascular Portfolio
↗
March 10, 2026
Medtronic announces a $550 million Scientia Vascular acquisition to strengthen its neurovascular portfolio.
Via
Benzinga
Is Edwards Lifesciences Stock Outperforming the S&P 500?
March 09, 2026
Edwards Lifesciences has outperformed the S&P 500 recently, and analysts remain moderately optimistic about the stock’s prospects.
Via
Barchart.com
Topics
Stocks
Macroeconomic Headwinds and Shifting Demand Force Healthcare Giants to Trim 2026 Outlooks
March 09, 2026
As the first quarter of 2026 draws to a close, the healthcare and life sciences sectors are grappling with a "new normal" defined by capital conservatism and geopolitical friction. Industry...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $1,000
↗
March 08, 2026
This Dividend King is out of favor, and this medical device peer has just introduced an exciting new product.
Via
The Motley Fool
2 Top Healthcare Dividend Stocks to Buy and Hold Forever
↗
March 05, 2026
These stocks can be slow-and-steady wealth compounders.
Via
The Motley Fool
Topics
Intellectual Property
Should You Buy MMED Stock After the MiniMed IPO?
March 03, 2026
MiniMed, a spinoff of Medtronic, is expected to price its IPO on March 5.
Via
Barchart.com
Topics
ETFs
Initial Public Offering
The Sleeper Stock That Could Surge Before Wall Street Notices
↗
March 01, 2026
Intuitive Surgical is the example to keep in mind as you watch this sleeper stock and its new surgical robot.
Via
The Motley Fool
Medtronic: The Only Medical Device Stock I'd Consider a Lifetime Hold
↗
February 28, 2026
The established medical device titan is expanding into a promising new direction -- robotic surgery.
Via
The Motley Fool
Topics
Intellectual Property
A Decade From Now, You'll Regret Not Buying This 1 Small-Cap Stock
February 26, 2026
The best long-term winners often start small.
Via
Barchart.com
Got $10,000? This Under‑the‑Radar Medical Device Giant Could Be a Millionaire Maker by 2036.
↗
February 26, 2026
One of the biggest growth stories in medical devices is Intuitive Surgical, but don't overlook the opportunity ahead for this competitor.
Via
The Motley Fool
Is Medtronic Stock Underperforming the S&P 500?
February 26, 2026
Medtronic has underperformed the S&P 500 over the past year. However, Wall Street analysts remain moderately optimistic about its prospects.
Via
Barchart.com
Topics
Initial Public Offering
Stocks
The Great Unlocking: Medtronic’s Strategic Pivot and the MiniMed Spin-Off
February 24, 2026
Date: February 24, 2026 By: Financial Research Analyst Introduction For years, Medtronic plc (NYSE: MDT) was viewed by Wall Street as a reliable but sluggish giant—a "Dividend Aristocrat" that offered...
Via
Finterra
Topics
Artificial Intelligence
Economy
Initial Public Offering
Medtronic Hits 10-Quarter High: PFA Dominance and Robotic Surges Signal a New Era for MedTech
February 23, 2026
In a definitive sign that the medical technology sector has moved past its post-pandemic stagnation, Medtronic (NYSE: MDT) reported its strongest enterprise revenue growth in ten quarters for the third...
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
1 Reason I'd Buy Medtronic Stock and Never Sell
↗
February 22, 2026
The stock is especially attractive to income seekers.
Via
The Motley Fool
Topics
Economy
Dividend Medtech Giant Medtronic Is Built to Survive Any Market Crash
↗
February 22, 2026
The company operates in a field where spending often isn't optional.
Via
The Motley Fool
Topics
Economy
Supply Chain
The Only Healthcare Stock I Would Buy and Never Sell Is Medtronic
↗
February 21, 2026
The only healthcare stock I own is Medtronic, and I'm not planning to sell it anytime soon.
Via
The Motley Fool
MarketBeat Week in Review – 02/16 - 02/20
↗
February 21, 2026
If investors are waiting for less market volatility, they’ll have to wait a little longer. The markets continued to oscillate between losses and gains as investors digested the impact of the U.S....
Via
MarketBeat
Topics
Government
World Trade
Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape
February 19, 2026
On January 15, 2026, the medical technology sector witnessed its most significant seismic shift in years as Boston Scientific Corporation (NYSE:BSX) announced a definitive agreement to acquire...
Via
MarketMinute
Medtronic Hits Ten-Quarter Growth Peak in Q3 Fiscal 2026, Signaling Resurgence in MedTech Sector
February 19, 2026
Medtronic (NYSE: MDT) reported its strongest enterprise revenue growth in ten quarters for its fiscal third quarter of 2026, marking a significant turning point for the medical technology giant. The...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
Danaher’s $9.9 Billion Acquisition of Masimo: A Strategic Pivot to the Future of Patient Monitoring
February 19, 2026
In a move that has sent shockwaves through the medical technology sector, Danaher Corporation (NYSE: DHR) announced on February 17, 2026, that it has entered into a definitive agreement to acquire...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Insulet (PODD) Shakes the Market with Q4 Earnings Beat as Omnipod 5 Dominance Continues
February 18, 2026
Insulet Corporation (NASDAQ:PODD) delivered a commanding performance in its fourth-quarter earnings report released today, February 18, 2026. The medical device leader announced an adjusted earnings...
Via
MarketMinute
Topics
Earnings
Medtronic Analysts Cut Their Forecasts After Q3 Earnings
↗
February 18, 2026
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
64
65
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.